|
US6544769B1
(en)
*
|
1996-12-13 |
2003-04-08 |
Schering Corporation |
Compostions comprising viruses and methods for concentrating virus preparations
|
|
US20080261289A1
(en)
*
|
1996-12-13 |
2008-10-23 |
Schering-Plough Corporation |
Compositions comprising viruses and methods for concentrating virus preparations
|
|
ES2185417T3
(es)
*
|
1998-12-03 |
2003-04-16 |
Avigen Inc |
Excipientes para usar en formulaciones farmaceuticas de virus adeno-asociados, y formulaciones farmaceuticas producidas con ellos.
|
|
US6759050B1
(en)
|
1998-12-03 |
2004-07-06 |
Avigen, Inc. |
Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith
|
|
US6225289B1
(en)
*
|
1998-12-10 |
2001-05-01 |
Genvec, Inc. |
Methods and compositions for preserving adenoviral vectors
|
|
FR2791999B1
(fr)
*
|
1999-04-09 |
2001-09-07 |
Aventis Pharma Sa |
Composition destinee a la conservation d'adenovirus recombinants infectieux
|
|
CA2364562A1
(fr)
*
|
1999-04-09 |
2000-10-19 |
Aventis Pharma S.A. |
Composition destinee a la conservation d'adenovirus recombinants infectieux
|
|
US7456009B2
(en)
|
2000-03-07 |
2008-11-25 |
Merck & Co., Inc. |
Adenovirus formulations
|
|
CA2399321C
(en)
|
2000-03-07 |
2013-04-30 |
Robert K. Evans |
Adenovirus formulations
|
|
WO2001085928A1
(en)
*
|
2000-05-10 |
2001-11-15 |
Mitsubishi Pharma Corporation |
Method of preparing virus vector
|
|
CA2469623C
(en)
|
2001-12-12 |
2012-05-29 |
F H Faulding & Co Limited |
Composition for the preservation of viruses
|
|
JP2005515245A
(ja)
*
|
2002-01-18 |
2005-05-26 |
シエーリング アクチエンゲゼルシャフト |
アデノウィルスの安定化された配合物
|
|
KR100507794B1
(ko)
*
|
2003-02-11 |
2005-08-17 |
한미약품 주식회사 |
고농도 레트로 바이러스 현탁액 제조 방법
|
|
US20070148765A1
(en)
*
|
2003-11-19 |
2007-06-28 |
Evans Robert K |
Preservative-containing virus formulations
|
|
CN101343625A
(zh)
*
|
2004-02-23 |
2009-01-14 |
克鲁塞尔荷兰公司 |
病毒纯化方法
|
|
GB0502661D0
(en)
*
|
2005-02-09 |
2005-03-16 |
Stabilitech Ltd |
A desiccated product
|
|
ES2317517T5
(es)
*
|
2005-04-11 |
2016-01-21 |
Crucell Holland B.V. |
Purificación de virus usando ultrafiltración
|
|
CN1961961B
(zh)
*
|
2005-11-11 |
2010-05-26 |
深圳市源兴生物医药科技有限公司 |
一种药物制剂及其制备方法
|
|
AU2009319254B2
(en)
|
2008-11-03 |
2015-04-30 |
Janssen Vaccines & Prevention B.V. |
Method for the production of adenoviral vectors
|
|
MX2012007936A
(es)
|
2010-02-15 |
2012-11-22 |
Crucell Holland Bv |
Metodo para la produccion de vectores adenovirales del serotipo 26 del adenovirus.
|
|
US8771709B2
(en)
|
2010-09-20 |
2014-07-08 |
Crucell Holland B.V. |
Therapeutic vaccination against active Tuberculosis
|
|
MX354752B
(es)
|
2010-09-27 |
2018-03-20 |
Janssen Vaccines & Prevention Bv |
Regimen de vacunacion de sensibilizacion y refuerzo heterologo contra malaria.
|
|
SG190418A1
(en)
|
2010-12-02 |
2013-07-31 |
Oncolytics Biotech Inc |
Liquid viral formulations
|
|
ES2630012T3
(es)
|
2010-12-02 |
2017-08-17 |
Oncolytics Biotech Inc. |
Formulaciones virales liofilizadas
|
|
AU2013231423B2
(en)
|
2012-03-12 |
2018-10-04 |
Janssen Vaccines & Prevention B.V. |
Batches of recombinant adenovirus with altered terminal ends
|
|
US8932607B2
(en)
|
2012-03-12 |
2015-01-13 |
Crucell Holland B.V. |
Batches of recombinant adenovirus with altered terminal ends
|
|
US9125870B2
(en)
|
2012-03-22 |
2015-09-08 |
Crucell Holland B.V. |
Vaccine against RSV
|
|
AU2013237424B2
(en)
|
2012-03-22 |
2017-07-06 |
Janssen Vaccines & Prevention B.V. |
Vaccine against RSV
|
|
CN104640564B
(zh)
|
2012-07-10 |
2020-08-04 |
特兰斯吉恩股份有限公司 |
分枝杆菌抗原疫苗
|
|
WO2014009433A1
(en)
|
2012-07-10 |
2014-01-16 |
Transgene Sa |
Mycobacterium resuscitation promoting factor for use as adjuvant
|
|
US10899800B2
(en)
|
2013-04-25 |
2021-01-26 |
Janssen Vaccines & Prevention B.V. |
Stabilized soluble pre-fusion RSV F polypeptides
|
|
BR112015031509B1
(pt)
|
2013-06-17 |
2023-05-09 |
Janssen Vaccines & Prevention B.V. |
Polipeptídeo de fusão (f) do vírus sincicial respiratório (rsv) pré- fusão recombinante e composição que o compreende
|
|
RU2695462C2
(ru)
|
2014-01-09 |
2019-07-23 |
Трансген Са |
Гибридизация гетероолигомерных микобактериальных антигенов
|
|
US9721484B2
(en)
|
2014-06-23 |
2017-08-01 |
Humanetics Innovative Solutions, Inc. |
Shoulder kit assembly for crash test dummy
|
|
EP3169341B1
(en)
|
2014-07-16 |
2019-06-05 |
Transgene SA |
Oncolytic virus for expression of immune checkpoint modulators
|
|
US10008130B2
(en)
|
2014-09-17 |
2018-06-26 |
Humanetics Innovative Solutions, Inc. |
Omni-directional shoulder assembly for crash test dummy
|
|
CA2975432A1
(en)
|
2015-02-13 |
2016-08-18 |
Transgene Sa |
Immunotherapeutic vaccine and antibody combination therapy
|
|
WO2016131945A1
(en)
|
2015-02-20 |
2016-08-25 |
Transgene Sa |
Combination product with autophagy modulator
|
|
AU2016249798B2
(en)
|
2015-04-14 |
2022-05-26 |
Janssen Vaccines And Prevention B.V. |
Recombinant adenovirus expressing two transgenes with a bidirectional promoter
|
|
BR112017027448A2
(pt)
|
2015-07-07 |
2018-09-04 |
Janssen Vaccines & Prevention Bv |
vacina contra rsv
|
|
WO2017005848A1
(en)
|
2015-07-07 |
2017-01-12 |
Janssen Vaccines & Prevention B.V. |
Stabilized soluble pre-fusion rsv f polypeptides
|
|
EA201892250A1
(ru)
|
2016-04-05 |
2019-03-29 |
Янссен Вэксинс Энд Превеншн Б.В. |
Вакцина против rsv
|
|
EA039095B1
(ru)
|
2016-04-05 |
2021-12-03 |
Янссен Вэксинс Энд Превеншн Б.В. |
Стабилизированные растворимые f-белки rsv до слияния
|
|
JP7046835B2
(ja)
|
2016-05-12 |
2022-04-04 |
ヤンセン ファッシンズ アンド プリベンション ベーフェー |
強力でバランスのとれた双方向性プロモーター
|
|
CN109311946A
(zh)
|
2016-05-30 |
2019-02-05 |
扬森疫苗与预防公司 |
稳定化的融合前rsv f蛋白
|
|
JP6683847B2
(ja)
|
2016-06-20 |
2020-04-22 |
ヤンセン ファッシンズ アンド プリベンション ベーフェーＪａｎｓｓｅｎ Ｖａｃｃｉｎｅｓ ＆ Ｐｒｅｖｅｎｔｉｏｎ Ｂ．Ｖ． |
強力でバランスのとれた双方向性プロモーター
|
|
WO2018011196A1
(en)
|
2016-07-14 |
2018-01-18 |
Janssen Vaccines & Prevention B.V. |
Hpv vaccines
|
|
TW201825511A
(zh)
|
2016-09-09 |
2018-07-16 |
美商艾斯合顧問有限公司 |
表現免疫檢查點調節子的溶瘤病毒
|
|
WO2018091680A1
(en)
|
2016-11-18 |
2018-05-24 |
Transgene Sa |
Cowpox-based oncolytic vectors
|
|
JP7110203B2
(ja)
|
2016-12-28 |
2022-08-01 |
トランジェーヌ |
腫瘍溶解性ウイルスおよび治療用分子
|
|
BR112019015671A2
(pt)
|
2017-02-09 |
2020-04-14 |
Janssen Vaccines & Prevention Bv |
promotor potente e curto para expressão de genes heterológicos
|
|
AU2018267971A1
(en)
|
2017-05-17 |
2019-11-07 |
Janssen Vaccines & Prevention B.V. |
Methods and compositions for inducing protective immunity against RSV infection
|
|
WO2018210871A1
(en)
|
2017-05-17 |
2018-11-22 |
Janssen Vaccines & Prevention B.V. |
Methods and compositions for inducing protective immunity against rsv infection
|
|
WO2019020543A1
(en)
|
2017-07-28 |
2019-01-31 |
Transgene Sa |
ONCOLYTIC VIRUSES EXPRESSING AGENTS TARGETING METABOLIC IMMUNE MODULATORS
|
|
CN111163800A
(zh)
|
2017-09-15 |
2020-05-15 |
扬森疫苗与预防公司 |
用于安全诱导针对rsv的免疫的方法
|
|
WO2020011754A1
(en)
|
2018-07-09 |
2020-01-16 |
Transgene |
Chimeric vaccinia viruses
|
|
EP3875119A4
(en)
|
2018-10-30 |
2022-08-31 |
The University of Tokyo |
ONCOLYTIC VIRUS FOR CANCER THERAPY
|
|
CR20210306A
(es)
|
2018-11-13 |
2021-07-22 |
Janssen Vaccines & Prevention Bv |
Proteínas f de prefusión del vrs estabilizadas
|
|
EP4097122A4
(en)
|
2020-01-31 |
2024-07-17 |
Beth Israel Deaconess Medical Center, Inc. |
COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING CORONAVIRUS INFECTION - SARS-COV-2 VACCINES
|
|
CA3168761A1
(en)
|
2020-03-19 |
2021-09-23 |
Minna HASSINEN |
Temperature-responsive virus storage system
|
|
CN116322740A
(zh)
|
2020-07-13 |
2023-06-23 |
特兰斯吉恩股份有限公司 |
免疫抑制的治疗
|
|
WO2022161502A1
(zh)
|
2021-02-01 |
2022-08-04 |
羿尊生物医药（浙江）有限公司 |
一种靶向蛋白降解系统及其应用
|
|
KR20230147156A
(ko)
|
2021-02-19 |
2023-10-20 |
얀센 백신스 앤드 프리벤션 비.브이. |
안정화된 융합 전 rsv fb 항원
|
|
WO2023020939A1
(en)
|
2021-08-17 |
2023-02-23 |
Janssen Pharmaceuticals, Inc. |
Sars-cov-2 vaccines
|
|
WO2023025899A2
(en)
|
2021-08-26 |
2023-03-02 |
Transgene |
Delivery system for targeting genes of the interferon pathway
|
|
WO2023111725A1
(en)
|
2021-12-14 |
2023-06-22 |
Janssen Pharmaceuticals, Inc. |
Sars-cov-2 vaccines
|
|
WO2023213763A1
(en)
|
2022-05-02 |
2023-11-09 |
Transgene |
Poxvirus encoding a binding agent comprising an anti- pd-l1 sdab
|
|
WO2023213764A1
(en)
|
2022-05-02 |
2023-11-09 |
Transgene |
Fusion polypeptide comprising an anti-pd-l1 sdab and a member of the tnfsf
|
|
JP2025523573A
(ja)
|
2022-07-01 |
2025-07-23 |
トランジェーヌ |
サーファクタントタンパク質－ｄとｔｎｆｓｆのメンバーを含んでなる融合タンパク質
|
|
EP4573113A1
(en)
|
2022-08-18 |
2025-06-25 |
Transgene |
Chimeric poxviruses
|